Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $734.06 billion, total revenue of $169.09 billion and a weighted average PE ratio of 41.22.
Market Cap
734.06B
Revenue
169.09B
Profits
17.81B
PE Ratio
41.22
Profit Margin
10.53%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 194.53B | -0.53% | 3,524,980 | 45.20B |
| 2 | DHR | Danaher Corporation | 125.84B | -10.99% | 28,098,194 | 25.11B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 43.58B | -2.01% | 429,122 | 4.45B |
| 4 | NTRA | Natera, Inc. | 38.26B | 1.73% | 994,675 | 2.50B |
| 5 | A | Agilent Technologies, Inc. | 37.52B | 2.00% | 2,383,955 | 7.23B |
| 6 | WAT | Waters Corporation | 36.09B | 2.80% | 1,169,991 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 33.65B | -1.12% | 1,029,677 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 29.13B | 4.25% | 1,365,148 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.23B | 1.92% | 174,812 | 4.09B |
| 10 | LH | Labcorp Holdings Inc. | 22.91B | -0.74% | 793,930 | 14.14B |
| 11 | DGX | Quest Diagnostics Incorporated | 22.90B | -0.39% | 691,873 | 11.28B |
| 12 | GH | Guardant Health, Inc. | 20.19B | 2.85% | 1,497,479 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.18B | 0.71% | 281,544 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 12.76B | 0.26% | 576,116 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.33B | 3.83% | 1,654,469 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 10.57B | -0.14% | 925,042 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.38B | 0.12% | 2,071,550 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 6.10B | 5.91% | 561,573 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.97B | 9.62% | 914,156 | 409.48M |
| 20 | SHC | Sotera Health Company | 4.96B | -0.11% | 2,776,755 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.87B | 1.96% | 459,206 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.75B | 3.96% | 864,533 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.61B | 3.29% | 3,505,219 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 3.12B | 5.51% | 482,794 | 156.12M |
| 25 | CDNA | CareDx, Inc. | 1.99B | 0.44% | 1,135,455 | 412.82M |
| 26 | NEO | NeoGenomics, Inc. | 1.88B | 1.47% | 1,577,869 | 745.97M |
| 27 | WGS | GeneDx Holdings Corp. | 1.83B | 1.65% | 772,643 | 442.68M |
| 28 | PSNL | Personalis, Inc. | 1.41B | 0.75% | 6,812,302 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 913.66M | 0.83% | 2,167,478 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 743.39M | 2.55% | 326,249 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 564.60M | 1.38% | 299,560 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 558.19M | -0.17% | 630,679 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 218.92M | 6.71% | 78,513 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 161.45M | 3.31% | 93,351 | 1.95M |
| 35 | XGN | Exagen Inc. | 117.42M | 3.85% | 234,358 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 99.66M | -6.16% | 6,820 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 42.36M | 1.28% | 85,145 | 25.83M |
| 38 | QUCY | Quantum Cyber N.V. | 26.41M | - | 486,290 | 537.08K |
| 39 | MDXH | MDxHealth SA | 21.73M | 1.51% | 214,267 | 110.97M |
| 40 | ADVB | Advanced Biomed Inc. | 11.70M | -20.45% | 1,828,678 | - |
| 41 | XWEL | XWELL, Inc. | 9.04M | -2.73% | 33,073 | 28.83M |
| 42 | MBAI | Check-Cap Ltd. | 7.47M | 7.89% | 24,477 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 6.81M | 8.39% | 23,079 | - |
| 44 | ISPC | iSpecimen Inc. | 3.25M | -2.59% | 38,888 | 1.03M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.19M | 0.89% | 128,048 | 5.66M |